The influence of lactose pseudopolymorphic form on salbutamol sulfate-lactose interactions in DPI formulations

Drug Development and Industrial Pharmacy

Volumn 34, Issue 9, 2008, Pages 992-1001

  Traini, Daniela ^a   Young, Paul M ^a   Thielmann, Frank ^b   Acharya, Manaswini ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Application Science   (United Kingdom)

Author keywords

DPI; Dry powder inhaler; IGC; In vitro; Lactose; Polymorph

Indexed keywords

CRYSTALLIN; DRUG CARRIER; LACTOSE; SALBUTAMOL; SALBUTAMOL SULFATE;

ADHESION; AEROSOL; ARTICLE; DRUG FORMULATION; DRY POWDER; GAS CHROMATOGRAPHY; PARTICLE SIZE; POWDER INHALER;

AEROSOLS; ALBUTEROL; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, GAS; LACTOSE; MICROSCOPY; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; X-RAY DIFFRACTION;

EID: 52149086340     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040802154889     Document Type: Article

References (40)

1. Beevers, C. A., & Hansen, H. N. (1971). Structure of alpha-lactose monohydrate. Acta Crystallogr., Sect. B: Struct. Crystallogr. Cryst. Chem., B 27(July 15), 1323-1325.
2. Brittain, H. G. (1999). Polymorphism in pharmaceutical solids. New York: Marcel Dekker.
3. Buma, T. J., & Wiegers, G. A. (1967). X-ray powder patterns of lactose and unit cell dimensions of beta-lactose. Neth. Milk Dairy J. -Nederlands-Nederlands Melk En Zuiveltijdschrift, 21(3-4), 208-213.
4. Bushill, J. H., Wright, W. B., Fuller, C. H. F., & Bell, A. V. (1965). Crystallisation of lactose with particular reference to its occurrence in milk powder. J. Sci. Food Agric., 16(10), 622-628.
5. Edge, S., Kibbe, A., & Kussendrager, K. (2006a). Anhydrous lactose. In R. C. Rowe, P. J. Sheskey, & S. C. Owen (Eds.), Handbook of pharmaceutical excipients (pp. 385-388). London: Pharmaceutical Press.
6. Edge, S., Kibbe, A., & Kussendrager, K. (2006b). Lactose monohydrate. In R. C. Rowe, P. J. Sheskey, & S. C. Owen (Eds.), Handbook of pharmaceutical excipients (pp. 389-395). London: Pharmaceutical Press.
7. Fries, D. C., Rao, S. T., & Sundaralingam, M. (1971). Structural chemistry of carbohydrates.3. crystal and molecular structure of 4-O-beta-d-galactopyranosyl-alpha-d-glucopyranose monohydrate alpha-lactose monohydrate. Acta Crystallogr., Sect. B: Struct. Crystallogr. Cryst. Chem., B 27(May 15), 994-1005.
8. Haleblian, J., & Mccrone, W. (1969). Pharmaceutical applications of polymorphism. J. Pharm. Sci., 58(8), 911-929.
9. Haleblian, J. K. (1975). Characterization of habits and crystalline modification of solids and their pharmaceutical applications. J. Pharm. Sci., 64(8), 1269-1288.
10. Hickey, A. J. (2005). Carriers in drug powder delivery. Am. J. Drug Delivery, 3(2), 117-132.
11. Hirotsu, K., & Shimada, A. (1974). Crystal and molecular-structure of beta-lactose. Bull. Chem. Soc. Jpn., 47(8), 1872-1879.
12. Holsinger, V. H. (1999). Lactose. In N. P. Wong, R. Jenness, M. Keeney, & W. H. Marth (Eds.), Fundamentals of dairy chemistry (3rd ed.). Gaithersburg: MD: Aspen Publishers.
13. Islam, N., Stewart, P., Larson, I., & Hartley, P. (2004). Lactose surface modification by decantation: Are drug-fine lactose ratios the key to better dispersion of salmeterol xinafoate from lactose-interactive mixtures? 2. Pharm. Res., 21(3), 492-499.
14. Jones, M. D., & Price, R. (2006). The influence of fine excipient particles on the performance of carrier-based dry powder inhalation formulations. Pharm. Res., 23(8), 1665-1674.
15. Jouppila, K., Kansikas, J., & Roos, Y. H. (1998). Crystallization and X-ray diffraction of crystals formed in water-plasticized amorphous lactose. Biotechnol. Prog., 14(2), 347-350.
16. Kawashima, Y., Serigano, T., Hino, T., Yamamoto, H., & Takeuchi, H. (1998). Effect of surface morphology of carrier lactose on dry powder inhalation property of pranlukast hydrate. Int. J. Pharm., 172(1-2), 179-188.
17. Kirk, J. H., Dann, S. E., & Blatchford, C. G. (2007). Lactose: A definitive guide to polymorph determination. Int. J. Pharm., 334(1-2), 103-114.
18. Larhrib, H., Zeng, X. M., Martin, G. P., Marriott, C., & Pritchard, J. (1999). The use of different grades of lactose as a carrier for aerosolised salbutamol sulphate. Int. J. Pharm., 191(1), 1-14.
19. Lefebvre, J., Willart, J. F., Caron, V., Lefort, R., Affouard, F., & Danede, F. (2005). Structure determination of the 1/1 alpha/beta mixed lactose by X-ray powder diffraction. Acta Crystallogr., Sect. B: Struct. Sci., 61, 455-463.
20. Lloyd, D. R., Ward, T. C., & Schreiber, H. P. (1989). Inverse gas chromatography: characterisation of polymers and other materials. Washington DC: American Chemical Society.
21. Louey, M. D., Mulvaney, P., & Stewart, P. J. (2001). Characterisation of adhesional properties of lactose carriers using atomic force microscopy 1. J. Pharm. Biomed. Anal., 25(3-4), 559-567.
22. Miller, S. P. F., Raw, A. S., & Yu, L. X. (2006). Scientific considerations of pharmaceutical solid polymorphism in regulatory applications. In R. Hilfiker (Ed.), Polymorphism (pp. 385-395). Weinheim: Wiley-VCH.
23. Platteau, C., Lefebvre, J., Affouard, F., & Derollez, P. (2004). Ab initio structure determination of the hygroscopic anhydrous form of a-lactose by powder X-ray diffraction. Acta Crystallogr., Sect. B: Struct. Sci., 60, 453-460.
24. Platteau, C., Lefebvre, J., Affouard, F., Willart, J. F., Derollez, P., & Mallet, F. (2005). Structure determination of the stable anhydrous phase of alpha-lactose from X-ray powder diffraction. Acta Crystallogr., Sect. B: Struct. Sci., 61, 185-191.
25. Pritchard, J. N. (2001). The influence of lung deposition on clinical response. J. Aerosol Med., 14, S19-S26.
26. Schultz, J.; Lavielle, L.; Martin, C. (1987). The role of interface in carbon fibre-epoxy composites. J. Adhes., 23,.45-51.
27. Simpson, T. D., Parrish, F. W., & Nelson, M. L. (1982). Crystalline forms of lactose produced in acidic alcoholic media. J. Food Sci., 47(6), 1948-1951.
28. Steckel, H., & Bolzen, N. (2004). Alternative sugars as potential carriers for dry powder inhalations. Int. J. Pharm., 270(1-2), 297-306.
29. Steckel, H., Markefka, P., teWierik, H., & Kammelar, R. (2004). Functionality testing of inhalation grade lactose. Eur. J. Pharm. Biopharm., 57(3), 495-505.
30. Thielmann, F. (2004). Introduction into the characterisation of porous materials. J. Chromatogr., A, 1037 (1-2), 115-120.
31. Traini, D., Young, P. M., Jones, M. D., Edge, S., & Price, R. (2006). Comparative study of erythritol and lactose monohydrate as carriers for inhalation: Atomic force microscopy and in vitro correlation. Eur. J. Pharm. Sci., 27(2-3), 243-251.
32. van Oss, C. J. (1994). Interfacial forces in aqueous media. New York: Marcel Dekker.
33. Young, P. M., Cocconi, D., Colombo, P., Bettini, R., Price, R., Steele, D. F., et al. (2002). Characterization of a surface modified dry powder inhalation carrier prepared by "particle smoothing". J. Pharm. Pharmacol., 54(10), 1339-1344.
34. Young, P. M., Edge, S., Traini, D., Jones, M. D., Price, R., El-Sabawi, D., et al. (2005). The influence of dose on the performance of dry powder inhalation systems 1. Int. J. Pharm., 296(1-2), 26-33.
35. Young, P. M., & Price, R. (2004). The influence of humidity on the aerosolisation of micronised and SEDS produced salbutamol sulphate. Eur. J. Pharm. Sci., 22(4), 235-240.
36. Young, P. M., Traini, D., Chan, H. K., Chiou, H., Edge, S., & Tee, T. (2007). The influence of mechanical processing dry powder inhaler carriers on drug aerosolisation performance. J. Pharm. Sci., 96(5), 1331-1341.
37. Young, P. M., Traini, D., & Edge, S. (2007). Advances in pulmonary therapy. In R. O. Williams, D. R. Taft, & J. T. McConville (Eds.), Advanced drug formulation design to optimize therapeutic outcomes. New York: Informa Healthcare.
38. Zeng, X. M., Martin, G. P., Marriott, C., & Pritchard, J. (2000). The influence of carrier morphology on drug delivery by dry powder inhalers. Int. J. Pharm., 200(1), 93-106.
39. Zeng, X. M., Martin, G. P., Marriott, C., & Pritchard, J. (2001a). Lactose as a carrier in dry powder formulations: The influence of surface characteristics on drug delivery. J. Pharm. Sci., 90(9), 1424-1434.
40. Zeng, X. M., Martin, G. P., Marriott, C., & Pritchard, J. (2001b). The use of lactose recrystallised from carbopol gels as a carrier for aerosolised salbutamol sulphate. Eur. J. Pharm. Biopharm., 51(1), 55-62.